A phase Ib/IIa, randomised, double-blind, multicentre trial to assess the safety and efficacy of expanded Cx611 allogeneic adipose-derived stem cells (eASCs) for the treatment of patients with community-acquired bacterial pneumonia admitted to the intensive care unit

BACKGROUND: Community-acquired bacterial pneumonia (CABP) can lead to sepsis and is associated with high mortality rates in patients presenting with shock and/or respiratory failure and who require mechanical ventilation and admission to intensive care units, thus reflecting the limited effectivenes...

Descripción completa

Detalles Bibliográficos
Autores principales: Laterre, Pierre-François, Sánchez-García, Miguel, van der Poll, Tom, de la Rosa, Olga, Cadogan, Kathy-Ann, Lombardo, Eleuterio, François, Bruno
Formato: Online Artículo Texto
Lenguaje:English
Publicado: BioMed Central 2020
Materias:
Study Protocol
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7686829/
https://www.ncbi.nlm.nih.gov/pubmed/33238991
http://dx.doi.org/10.1186/s12890-020-01324-2

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7686829/
https://www.ncbi.nlm.nih.gov/pubmed/33238991
http://dx.doi.org/10.1186/s12890-020-01324-2

Ejemplares similares